The drug was observed to effectively curb appetite, hunger, impulsivity, cravings, and food cue responsiveness, particularly with regard to high-sugar and high-fat foods, suggesting potential early mechanisms underlying Tirzepatides powerful weight-loss effects
Participants started at a dose of 0.6 mg per week, which was doubled every two weeks to reach 2.4 mg per week by the fourth week
Importantly, none of the trials in T1D reported an increase in diabetic ketoacidosis (DKA) a key concern that has limited the use of SGLT2 inhibitors in T1D
This dose was tested in a multicenter phase III clinical trial in 609 participants with early-stage Huntingtons disease
It's reserved for risks that are deemed particularly serious, says Caleb Alexander, MD, MS, professor in Epidemiology and co-director of the Center for Drug Safety and Effectiveness
CK-MB, creatine kinase isoenzyme-MB